NCT06079346 A Study of OT-101 With mFOLFIRINOX in Patients With Advanced and Unresectable or Metastatic Pancreatic Cancer Status RECRUITING Phase PHASE2/PHASE3
NCT05425576 OT-101 in Combination With Pembrolizumab in Subjects With Malignant Pleural Mesothelioma Failing to Respond to Checkpoint Inhibition Status NOT_YET_RECRUITING Phase PHASE2
NCT04801017 A Study to Evaluate the Safety and Efficacy of OT-101+Artemisinin in Hospitalized COVID-19 Subjects Status UNKNOWN Phase PHASE2